Miñones and Aemps commit to flu and COVID-19 vaccination campaign

Ministers and Aemps chiefs at a hearing on Wednesday.

Health Minister José Minones and the director of the Spanish Agency for Medicines and Health Products (Aemps), Maria Jesús Lamas, assessed the flu and COVID-19 vaccination campaign to be launched this fall.

Influenza and covid-19 vaccination recommendations for the 2023-2024 season, approved at the last plenary meeting of the Interterritorial Council in July, include revisions to the composition of two influenza vaccines that have been altered relative to Previous vaccination campaigns, in addition to collecting target groups who should be prioritized for these vaccines and the Covid-19 vaccine, focused on people over 60 years old, high-risk groups and pregnant women.

In addition, the document makes recommendations for groups of children aged 6 to 59 months and persons aged 5 to 59 who are at greater risk of derivative complications, such as smokers and children aged 5 to 18 on long-term treatment. people. Acetylsalicylic acid, because Reye’s syndrome may develop after the flu.

Influenza and Covid-19 vaccination campaigns will start in October. Vaccinations for persons with disabilities and persons aged 80 and over in nursing homes and other care centers may be prioritized, and due to the strategic importance played by health and social health personnel, their vaccinations may also be prioritized. “Vaccination will continue until the end of the seasonal season. Vaccines against Covid-19 may be administered outside of vaccination campaigns to persons who request them following an individualized assessment. In these cases, the time interval from previous vaccination or infection (for at least 5 months)”, the ministry assured.

At a meeting at Aemps headquarters on Wednesday, ministers and directors agreed on a commitment to protect and promote people’s health, wellness and the environment.

Likewise, the meeting also discussed a range of issues related to the actions the agency will take to ensure the quality, safety, efficacy, information and accessibility of medicines, according to the Ministry of Health,

During his visit, Mignones was also interested in the work being done in the Aemps lab.

☰